Delaying Treatment Worsens Head, Neck Cancer Outcomes
Findings show that survival declines, recurrence increases with delays of more than 60 days.
Head and Neck Cancer
Which Feeding Tubes Do Head and Neck Cancer Clinicians Prefer to Use in Patients Undergoing Radiotherapy?
Nasogastric tubes placed reactively or gastrostomy tubes placed prophylactically? Head and neck cancer experts weigh in on which they, and their patients, prefer to use.
Comparison Study Shows Predictive Value for CSCC of the Head and Neck of BWH vs AJCC 8
A team of researchers sought to determine if BWH Tumor Classification System classified tumors more accurately than AJCC 8, and their sensitivity and specificity for predicting poor outcomes.
Rozlytrek, a Tumor Agnostic Therapy, Receives FDA Approval
The Food and Drug Administration (FDA) has granted accelerated approval to Rozlytrek (entrectinib; Genentech)
Factors Associated With Thyroid Cancer Overtreatment Identified
Overtreatment more likely in younger, male, Hispanic or Asian patients, those with extensive lymph node surgery.
Head and Neck Cancers Treatment Regimens
View detailed treatment regimens for head and neck cancers, with options such as cisplatin, cisplatin + radiotherapy, and more.
The Effect of Concurrent Implementation of a Nurse Navigator and Pretreatment Care Map on Time to Treatment for Head and Neck Cancer Patients
Researchers report on implementation of a nurse navigator and pretreatment care plans on time from diagnosis to treatment for patients with head and neck cancers.
ASCO: Low-Dose Chemotherapy Benefits Advanced Gastroesophageal Cancer
Elderly, frail receiving 60 percent of oxaliplatin/capecitabine dose have noninferior PFS, less toxicity.
Etiology and Management of Nasopharyngeal Hemorrhage After Radiotherapy for Nasopharyngeal Carcinoma
[Cancer Management and Research] Chinese researchers present a review of a rare cancer and strategies for managing the most common adverse effect of its treatment.
Enhanced Reimbursement Incentives for Generic Cancer Drugs Found Not to Affect Prescribing Patterns
Critics of the study say they are not surprised by the study’s conclusions, as oncologists make treatment decisions based on best treatment course, not money.
Next post in General Oncology
